299 related articles for article (PubMed ID: 18929611)
1. P50 gating at acute and post-acute phases of first-episode schizophrenia.
Devrim-Uçok M; Keskin-Ergen HY; Uçok A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1952-6. PubMed ID: 18929611
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic effects on auditory sensory gating in schizophrenia patients.
Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
Eur Neuropsychopharmacol; 2009 Dec; 19(12):905-9. PubMed ID: 19833483
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
[TBL] [Abstract][Full Text] [Related]
4. P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment.
Oranje B; Aggernaes B; Rasmussen H; Ebdrup BH; Glenthøj BY
Schizophr Bull; 2013 Mar; 39(2):472-80. PubMed ID: 22241164
[TBL] [Abstract][Full Text] [Related]
5. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients.
Brockhaus-Dumke A; Schultze-Lutter F; Mueller R; Tendolkar I; Bechdolf A; Pukrop R; Klosterkoetter J; Ruhrmann S
Biol Psychiatry; 2008 Sep; 64(5):376-84. PubMed ID: 18395700
[TBL] [Abstract][Full Text] [Related]
6. Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients.
Chen XS; Li CB; Smith RC; Xiao ZP; Wang JJ
Psychiatry Res; 2011 Aug; 188(3):327-33. PubMed ID: 21216472
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
Moxon KA; Gerhardt GA; Adler LE
Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
[TBL] [Abstract][Full Text] [Related]
8. An initial report of a new biological marker for bipolar disorder: P85 evoked brain potential.
Patterson JV; Sandman CA; Ring A; Jin Y; Bunney WE
Bipolar Disord; 2009 Sep; 11(6):596-609. PubMed ID: 19689502
[TBL] [Abstract][Full Text] [Related]
9. A follow-up study on features of sensory gating P50 in treatment-resistant depression patients.
Wang Y; Fang YR; Chen XS; Chen J; Wu ZG; Yuan CM; Yi ZH; Hong W; Zhang C; Cao L
Chin Med J (Engl); 2009 Dec; 122(24):2956-60. PubMed ID: 20137481
[TBL] [Abstract][Full Text] [Related]
10. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
[TBL] [Abstract][Full Text] [Related]
11. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.
Knott V; Millar A; Fisher D; Albert P
Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902
[TBL] [Abstract][Full Text] [Related]
12. [Sensory gating of patients with first-episode schizophrenia].
Chen XS; Zhang MD; Wang HX; Lou CY; Wang JJ; Guo Q; Liu L; Gao CY; Liu P; Liu XW; Duan HJ; Guo FL; Liang JH; Chen C; Chen XW
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3457-9. PubMed ID: 16686059
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients.
Zhang J; Abdallah CG; Wang J; Wan X; Liang C; Jiang L; Liu Y; Huang H; Hong X; Huang Q; Wu R; Xu C
Psychiatry Res; 2012 Dec; 200(2-3):126-32. PubMed ID: 22705363
[TBL] [Abstract][Full Text] [Related]
14. Auditory verbal hallucinations in schizophrenia correlate with P50 gating.
Smith DM; Grant B; Fisher DJ; Borracci G; Labelle A; Knott VJ
Clin Neurophysiol; 2013 Jul; 124(7):1329-35. PubMed ID: 23490551
[TBL] [Abstract][Full Text] [Related]
15. Comparison of midlatency auditory sensory gating at short and long interstimulus intervals.
Rentzsch J; de Castro AG; Neuhaus A; Jockers-Scherübl MC; Gallinat J
Neuropsychobiology; 2008; 58(1):11-8. PubMed ID: 18781086
[TBL] [Abstract][Full Text] [Related]
16. Gating of auditory P50 in schizophrenics: unique effects of clozapine.
Nagamoto HT; Adler LE; Hea RA; Griffith JM; McRae KA; Freedman R
Biol Psychiatry; 1996 Aug; 40(3):181-8. PubMed ID: 8830951
[TBL] [Abstract][Full Text] [Related]
17. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
[TBL] [Abstract][Full Text] [Related]
18. [P50 component of auditory evoked potentials in persons with schizophrenia and their first degree relatives].
Wegrzyn J; Wciórka J
Psychiatr Pol; 2004; 38(3):395-408. PubMed ID: 15199650
[TBL] [Abstract][Full Text] [Related]
19. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia.
Myles-Worsley M; Ord L; Blailes F; Ngiralmau H; Freedman R
Biol Psychiatry; 2004 Apr; 55(7):663-7. PubMed ID: 15038993
[TBL] [Abstract][Full Text] [Related]
20. [Sensory gating P50 in schizophrenic patients with and without homicide].
Wang HX; Zhen WF; Ma X; Wang YP; Tian JH; Dou QS; Zhao HX
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2616-20. PubMed ID: 20137678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
